IP Group PLC
Investor profile
Corporate
Deals
15
distinct rounds
Companies
9
backed
Active span
2014–2026
13 yrs
Total round €
€262M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- M Ventures3
- Oxford Capital Partners3
- Parkwalk Advisors3
- Pfizer Ventures3
- Woodford Investment Management3
- Taiho Ventures2
- UTokyo Innovation Platform2
- Andera Partners1
- Avidity Partners1
- Cambridge Innovation Capital1
- Cornes1
- Dolby Family Ventures1
- Earlybird Venture Capital1
- EQT Life Sciences1
- Fast Track Initiative1
- Fast Track Initiative (FTI)1
- Finance Wales1
- Invus1
- Janus Henderson Investors1
- Mercia Ventures1
- North East Technology Fund1
- Novartis Venture Fund1
- Omega Funds1
- Panakès Partners1
- Par Equity1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Artios | UK | 1 | €99M |
| Storm Therapeutics | UK | 2 | €76M |
| Ultrahaptics | UK | 4 | €56M |
| Mirriad | UK | 1 | €14M |
| Arkivum | UK | 3 | €7.7M |
| Alesi Surgical | Ireland | 1 | €6.0M |
| DUnited Kingdomosi | UK | 1 | €2.2M |
| Zeetta | UK | 1 | €1.6M |
| Refract | UK | 1 | €600k |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Artios | Series D+ | €99M | 2025-11 |
| Storm Therapeutics | Series C | €48M | 2026-04 |
| Storm Therapeutics | Series B | €28M | 2022-12 |
| Ultrahaptics | Other | €23M | 2017-05 |
| Ultrahaptics | Other | €20M | 2017-05 |
| Mirriad | Series D+ | €14M | 2016-02 |
| Ultrahaptics | Series A | €12M | 2015-10 |
| Alesi Surgical | Other | €6.0M | 2017-05 |
| Arkivum | Series C | €3.6M | 2016-10 |
| Arkivum | Series C | €2.6M | 2014-03 |